相关实验视频
Updated: Jan 18, 2026
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
1.5K
在透析患者中新旧结合剂的有效性差异:系统性审查和元分析
Fortunata Zirino1, Veronica Maressa2, Roberta Maria Messina1
1Unit of Nephrology and Dialysis, P.O. Maggiore "Nino Baglieri", Modica (RG), Italy.
概括
环环酸盐 (SZC) 和聚二硫酸盐 (SPS) 在透析患者中有效降低. 帕蒂罗默没有显著影响,需要对较新的结合剂进行更多研究.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 超高血是透析患者的一个严重并发症.
- 新的结合剂,如帕蒂罗默和SZC提供了更好的耐受性.
- 较旧的结合剂包括聚二硫酸盐 (SPS) 和聚二硫酸盐 (CPS).
研究的目的:
- 在透析患者中评估较新的结合剂 (帕蒂罗默,SZC) 的疗效和安全性.
- 将这些结合剂与安慰剂和较老的药物 (SPS,CPS) 相比较.
主要方法:
- 按照PRISMA指南进行随机对照试验 (RCT) 的系统审查和元分析.
- 在 MEDLINE,PubMed,CINAHL 和 EMBASE 搜索到 2024 年 11 月 1 日.
- 包括在透析患者中将patiomer或SZC与安慰剂,SPS或CPS进行比较的RCT.
主要成果:
- 分析了6个RCT,包括3155名患者.
- 与安慰剂相比,SZC和SPS显著降低了透析前 (p<0.0001).
- 与安慰剂相比,Patiromer没有显著降低 (p=0.16).
- 所有的结合剂都降低了高血事件;安全性数据有限但可比.
- 在新和旧的结合剂/安慰剂之间观察到高异质性.
结论:
- 在透析患者中,SZC和SPS有效降低透析前水平.
- 在此分析中,帕蒂罗默的疗效在统计学上并不显著.
- 需要进一步的研究来直接比较较新的结合剂,并评估长期结果.
相关概念视频
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
2.2K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.2K
01:22Heart Failure Drugs: Diuretics
812
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
812
01:20Acute Kidney Injury V: Interprofessional Care
297
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
297
01:28Chronic Kidney Disease III: Interprofessional Care
346
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
346
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
211
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
211
01:22Acute Kidney Injury VI: Nursing Management
398
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
398